Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2018-11-30 2018-09-28
Drug Identification Number 02318059 02318059
Brand name APO-ATOMOXETINE APO-ATOMOXETINE
Common or Proper name APO-Atomoxetine 40mg APO-Atomoxetine 40mg
Company Name APOTEX INC APOTEX INC
Ingredients ATOMOXETINE ATOMOXETINE
Strength(s) 40MG 40MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100BTL 100BTL
ATC code N06BA N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-09-26 2018-09-26
Estimated end date 2018-12-28 2018-12-28
Actual end date 2018-11-29
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments